• Esperion Therapeutics (NASDAQ:ESPR) Receives "Buy" Rating from HC Wainwright

    Source: Buzz FX / 21 Mar 2025 11:06:17   America/Chicago


    Esperion Therapeutics (NASDAQ:ESPR) Receives "Buy" Rating from HC Wainwright Written by MarketBeat March 21, 2025 Share Link copied to clipboard. Remove Ads Esperion Therapeutics ( NASDAQ:ESPR - Get Free Report ) 's stock had its "buy" rati
    Read more...
Share on,